ArticleJournal for immunotherapy of cancer2025

Comment on 'Tumor mutational burden and survival on immune checkpoint inhibition in >8000 patients across 24 cancer types'.

Jiawen Bu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.